Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

PATOGENETIChESKAYa SVYaZ' SERDEChNO-SOSUDISTOY PATOLOGIII OSTEOPOROZA U PATsIENTOV STARShIKh VOZRASTNYKh GRUPP.OBZOR DANNYKh LITERATURY

Abstract


Last years a lot of researches in the world were devoted to the problem of relationship between cardiovascular diseases and osteoporosis at elderly patients. According to results of these researches were shown several uniforms pathogenetic mechanisms, and now it allows us to tell about them as about «calcium scarce illnesses». Now there are bases to recognize existence of the general pathologic mediators of the bone and cardiovascular systems which leads to develop of diseases of heart and vessels. Knowledge of the general laws of patho-genesis will allow developing more effective measures on preventive maintenance of their complications and decreasing the frequency of these diseases.

O B Ershova

A V Nazarova

K Yu Belova

  1. Эрдес Ш. Обращение ВОЗ по поводу декады заболеваний костей и суставов. Остеопороз и остеопатии 2000; (2): 2-3.
  2. Demystifying the myths of ageing. World Health Organization 2008. Edited by Anna Ritsatakis.
  3. UNFPA annual report 2007. UNFPA 2008.с.30, www. unfpa.org.
  4. Данные Росстата о демографической ситуации в РФ. По материалам конференции «Семья, дети и демографическая ситуация в России», Москва, 17 октября 2006 г.
  5. Шварц Г.Я. Остеопороз, падения и переломы в пожилом возрасте: роль D-эндокринной системы. Русский медицинский журнал. Ревматология. 2008; 16 (10): 660-669.
  6. Голдстейн Л.Б. и др. (пер. с англ. И.В.Саньковой). Ранняя профилактика ишемического инсульта: Заявление для специалистов медико-санитарной службы, сделанное Советом по проблемам инсульта при Американской ассоциации кардиологов. Circulation 2001; 103: 163-182. М.: ГВГ им. Н.Н.Бурденко, 2002: 49.
  7. Gullberg В., Johnell O., Kanis J.A. World-wide projections for hip fracture. Osteoporosis Int., 1997; 7:407-413.
  8. Беневоленская Л.И. Остеопороз: проблема остеопороза в современной медицине Consilium Medicum 2004; 6 (2): 96-99.
  9. Сидоренко Б.А., Преображенский Д.В., Скорик А.В. и др. Профилактика мозгового инсульта с помощью антигипертензивных препаратов: преимущества и ограничения антагонистов кальция. Справочник поликлинического врача 2007; 11: 29-34.
  10. Оганов Р.Г. Эпидемиология артериальной гипертонии. Справочник поликлинического врача 2007; 12: 22-23.
  11. Шальнова С.А., Деев А.Д., Вихирева О.В., Оганов Р.Г. Распространенность артериальной гипертонии в России. Информированность, лечение, контроль. Профилакт. заболев. и укрепл. здор. 2001; 2: 3-7.
  12. Чазова И.Е. Проблема лечения артериальной гипертонии в России. Справочник поликлинического врача 2007; 12: 23.
  13. Беневоленская Л.И. Остеопороз - актуальная проблема медицины. Остеопороз и остеопатии 1998; 1: 4-7.
  14. Johnell O., Kanis J.A., Oden A. et al. B. Mortality after osteoporotic fractures. Osteoporosis Int. 2004; 15: 38-42.
  15. Беневоленская Л.И. (ред.). Руководство по остео-порозу. М.: «Бином»; 2003. 91, 261-288, 320-346.
  16. Luz Villa M., Nelson L. Race, ethnicity, and osteoporosis. In: Marcus R., Feldman D., Kelsey J., eds. Osteoporosis, San Diego: Academic Press, 1996: 435-448.
  17. Melton L.J. 3-d. Differing patterns of osteoporosis across the world.// In: Chesnut CH, Ed. New dimensions in osteoporosis in the 1990. Hong Kong, Excerpta Medica Asia, 1991: 13-18.
  18. Маличенко С.Б., Колосова И.Р. Профилактика и лечение первичного остеопороза у лиц старшего возраста. Справочник поликлинического врача 2005; 3 (2): 44-47.
  19. Беневоленская Л.И., Михайлов Е.Е., Торопцова Н.В. Проблема остеопороза в современном мире. Русский медицинский журнал 2005; 24: 1582-1585.
  20. Melton L.J. 3-d.Perspectives: how many women have osteoporosis now? J.Bone Miner. Res., 1995; 10:175-177.
  21. Торопцова Н.В., Баркова Т.В., Беневоленская Л.И. и др. Распространенность остеопении и остеопороза среди населения г. Москвы в возрасте 50 лет и старше. Третий Российский симпозиум по остеопорозу: Тезисы лекций и докладов. СПб.; 2000: 73-76.
  22. Ballard P.A., Purdie D.W., Langton C.М. et al. Osteoporosis Int 1998; 8: 535-9.
  23. Bronco J.C., Briosa A., Guvares V.,Arriano B. Osleoporos Int 1996; 6 (suppl.): 109.
  24. Chiang A., Jones J., Humphreys J., Martin C. Osteoporosis-diagnosis and treatment in a general practice population. Aust Fam Physician. 2006 Mar;35(3):166-8.
  25. Peres-Castrillon J.L., de Luis D., Duenas-Laita A. Atherosclerosis and osteoporosis. Minerva Med. 2008; 99 (1): 4-54.
  26. Danilevicius C.F., Lopes J.B., Pereira R.M.R. Bone metabolism and vascular calcification. Brazilian Journal of Medical and Biological Research 2007; 40: 435-442.
  27. Perez-Castrillon J..L, Martin-Escudero J.C., Alvarez Manzanares P. et al. Hypertension as a risk fa.ctor for hip fracture. Am J Hypertens. 2005 Jan;18(1):146-7.
  28. Alagiakrishnan K., Juby A., Hanley D. et al. Role of vascular factors in osteoporosis. J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):362-6.
  29. Warburton D.E., Nicol C.W., Gatto S.N. et al. Cardiovascular disease and osteoporosis: balancing risk management. Vasc Health Risk Manag. 2007;3(5):673-89.
  30. Sennerby U., Farahmand B., Ahlbom et al. Cardiovascular diseases and future risk of hip fracture in women. Osteoporosis Int. 2007 Oct;18(10):1355-62. Epub 2007 May 10.
  31. Farhat G.N., Newman A.B., Sutton-Tyrrell K. et al. Health ABC Study. The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporosis Int. 2007 Jul;18(7):999-1008. Epub 2007 Feb 7.
  32. Browner W. S., Sooley D.G., Vogt T.M. Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991; 338: 335-338.
  33. Browner W.S., Pressman A.R., Nevitt M.C. et al. Association between low density and stroke in elderly women. Stroke 1993; 24: 940-946.
  34. Насонов Е.Л. Роль кальция, витамина D и тиазид-ных диуретиков в профилактике и лечении остеопороза. Русский медицинский журнал 1997; 5: 978-982.
  35. Devine A., Dick I.M., Heal S.J. et al. A 4-year follow-up study of the effect of calcium supplementation on bone density in elderly postmenopausal women. Osteoporosis Int. 1997; 7: 23-28.
  36. Gandolini G., Grossi E., Bevilacqua M., et al. Is the association between hypertension and bone osteoporotic fracture expressing a real interdependence? Ciue from GISMO Lombardia database. J Bone Miner Res 2008: Vol 23:S 329, Abstract SU346.
  37. Скрипникова И.А., Поддубская Е.А., Берзак Н.В. и др. Современные подходы к диагностике и профилактике остеопороза и сердечно-сосудистых заболеваний у женщин с естественной и хирургической менопаузой. Пособие для врачей. Москва 2005. c .33.
  38. Маличенко С.Б, Колосова И.Р. Варежкина И.А. Первичный остеопороз: взаимосвязь патологии костной и сердечно-сосудистой системы у пожилых Consilium Medicum 2004; 6 (12): 1375-1383.
  39. Fujita T. Osteoporosis: past, present and future. Osteoporosis Int. 1997:7 (Suppl.3):S6-9.
  40. Samelson E.J., Massaro J.M., Fox C.S., Tucker K.L., Booth S.L., Wang T.J. et al. Calcium intake is not associated with increased coronary artery calcification: The Framingham QCT Study. Journal of bone and mineral research 2008: Vol 23:S 58, Abstract 1207.
  41. Banks L.M., Macsweeney J.E., Stevenson J.C. Effect of degenerative spinal aortic calcification on bone density measurements in postmenopausal women: links between osteoporosis and cardiovascular disease? Eur. J.Clin. Invest. 1994; 24: 813-817.
  42. Frye M.A., Melton L.J., Bryant S.C. et al. Osteoporosis and calcification of aorta. Bone miner. 1992; 19: 185-194.
  43. Ouchi Y., Akashita M., DeSuoza A.C. et al. Age-related loss of bone mass and aortic/aortic valve calcification-reevaluation of recommended dietary allowance of calcium in the elderly. Ann. N.Y. Acad. Sci 1993; 676: 297-307.
  44. Barengolts E.L., Berman M., Kukreja S.C. et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif. Tissue Int. 1998; 62: 209-213.
  45. Choi S.H., An J.H., Lim S., Koo B.K. et al. Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin Endocrinal (Oxf). 2009 Nov;71(5):644-51.
  46. Laroche M., Pouilles J.M., Ribot C. et al. Comparison of the bone mineral content of the lower limbs in man with ischemic atherosclerotic disease/ Clin. Rheum. 1994; 13: 611-614.
  47. Danilevicius C.F., Lopes J.B., Takayama L., Caparbo V.F., Oliveira I.R.S., Kuroishi M.E., et al. Association between vascular calcification and low total femur bone mineral density in elderly people community-dwelling. J Bone Miner Res 2008: Vol 23: S358, Abstract SU453.
  48. Demer L.L. A skeleton in the atherosclerosis closet. Circulation 1995; 92: 2029-2032.
  49. Byon ., Chen J., McDonald J., Chen Y. Bridging vascular calcification and osteoporosis: the function of receptor activator of nuclear factor kB. J Bone Miner Res 2008: Vol 23:S 480, Abstract M419.
  50. Christiansen C., Karsdal M., Ganz M., Dam E., Nielsen M. Morphological atherosclerosis calcification distribution (MACD) index is a strong predictor of cardio-vascular death and include the predictive power of BMD. J Bone Miner Res 2008: Vol 23: S361, Abstract SU463.
  51. Choi W.H., Han H., Hong S.M., Ahn Y.H. The Association Between Several Factors Affecting Aortic Calcification and Bone Mineral Density In Postmenopausal Women. J Bone Miner Res 2008: Vol 23:S 225, Abstract SA489.
  52. Parham I. F., Morrow A.D., Balucan J. et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. Arterioscler. Tromb. Vasc. Biol. 1997; 17: 680-687.
  53. Голубева Н.С. Факторы риска сердечно-сосудистых заболеваний у женщин старших возрастных групп с остеопорозом. Автореферат кандидатской диссертации 2007.
  54. Аникин С.Г., Беневоленская Л.И., Демин Н.В. и др. Остеопороз и кардиоваскулярная патология. Тезисы докладов третьего конгресса по остеопорозу. Екатеринбург; 2008: 90.
  55. Robertson K., Norgard M., Windahl S., Hultenby K., Ohlsson C., Gustafsson J. et al. The cholesterol sensing receptors, liver X receptor а and Р, have novel and distinct roles in osteoclast differentiation and activation in bone. Journal of bone and mineral research 2008: Vol 23:S 93, Abstract F085.
  56. Izu Y., Hayata T., Mizoguchi F. et al. Angiotensin II Type 2 Receptor Blockade Increases Bone Mass. J Bone Miner Res 2008: Vol 23:S 245, Abstract SU007.
  57. Lirani-Galvao A.P.R., Chavassieux P., Portero-Muzy N. et al. The Effects of Electrical Stimulation on Nitric Oxide Expression and Osteocyte Viability in Ovariectomized Rats. J Bone Miner Res 2008: Vol 23:S 233, Abstract SA524.
  58. Uemura T., Ohta Y., Nakao Y., Hashimoto Y., Takaoka K. Catecholamines accelerate BMP-induced osteoblastic differentiation and bone formation. J Bone Miner Res 2008: Vol 23:S 275, Abstract SU137.
  59. Bonnet N., Pierroz D., Ferrari S. Low bone mass and decreased biomechanical response in beta 1 adrenergic receptor KO but in beta 2 adrenergic receptor KO mice. Journal of bone and mineral research 2008: Vol 23:S41, Abstract 1141.
  60. Fonseca T.L., Costa C.C., Moulatlet A.C., FreitasR.S., Brum P.C., Gouveia C.H.A. Double deletion of a2a- and a2c-adrenergic receptors results in a phenotype of high bone mass and resistance to the thyrotoxicosis-induced osteopenia. Journal of bone and mineral research 2008: Vol 23:S 105, Abstract F244.
  61. LaCroix A.Z., Cauley J.A., Pettinger M. et al. Statin use, clinical fracture and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study. Ann. Inter. Med. 2003; 139: 97-104.
  62. Bauer D.C., Mundy G.R., Lamal S.A. et al. Use of statins and fracture. Resalts of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Ann. Inter. Med. 2004; 164: 146-152.
  63. Toh S, Hernandez-Diaz S. Statins and fracture risk. A systematic review. Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):627-40.
  64. Schlinger R.G., Kraenzlin M.E., Jick S.S. et al. Use of beta-blockers and risk of fractures. JAMA 2004; 292 (11): 1326-1332.
  65. Rejnmark L., Vestergaard P., Kassem M. et al. Fracture risk in perimenopausal women treated with B-blockers. Calcif. Tissue. Int. 2004; 75 (5): 365-372.
  66. Perez-Castrillon J.L., Silva J., Justo I. et al. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. Am. J. Hypertens. 2003; 16 (6): 453-459.
  67. Legroux-Gerot I., Catanzariti L., Marchandise X et al. Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics. Joint Bone Spine 2004; 71 (1): 51-55.
  68. Sigurdsson G., Franzson L. Increased bone mineral density in a population-based group of 70-yer-old women on thiazide diuretics, independent of parathyroid hormone levels. J. Intern. Med. 2001; 250 (1): 51-56.
  69. Zacharieva S., Shigarminova R., Nachev E., et al. Effect of amlodipine and hormone replacement therapy on blood pressure and bone markers in menopause. Methods Find Exp Clin Pharmacol. 2003; 25 (3):209-213.

Views

Abstract - 363

PDF (Russian) - 473

Cited-By


PlumX


Copyright (c) 2009 Ershova O.B., Nazarova A.V., Belova K.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.